Abner, Herrman & BrocK »

Brainstorm Cell Therapeutics shares owned by Abner, Herrman & BrocK

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics shares owned by Abner, Herrman & BrocK from 13F filings

Historical chart of Abner, Herrman & BrocK investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Abner, Herrman & BrocK consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Abner, Herrman & BrocK

Quarter filed Position value Share count Share price at filing
2024-09-30 $34k 146k 0.23

More positions owned by Abner, Herrman & BrocK

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
International Business Machines (IBM)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Oracle Corporation (ORCL)
Netflix (NFLX)
Morgan Stanley (MS)
Apple (AAPL)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
American Express Company (AXP)
salesforce (CRM)
MasterCard Incorporated (MA)
Chubb (CB)

View all positions for Abner, Herrman & BrocK

Top funds holding Brainstorm Cell Therapeutics

Abner, Herrman & BrocK
D. J. St. Germain
Bogart Wealth

View all funds holding Brainstorm Cell Therapeutics